Inwardly Rectifying Potassium Channels in the Regulation of Vascular Tone
Journal:
Current Drug Targets
Volume:
4
Page:
281-289
Author(s):
Sophocles Chrissobolis and Christopher G. Sobey
Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
291-296
Author(s):
E. Fonsatti, M. Altomonte, P. Arslan and M. Maio
Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1013-1022
Author(s):
B. C. Yegen
Clinical Trials Targeting Advanced Cancers by Active Immunization of T-cell Defined Tumor Antigens
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1133-1138
Author(s):
Hideyuki Ikeda
Clinical Aspects of Clara Cell 10-kDa Protein / Uteroglobin (Secretoglobin 1A1)
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1139-1149
Author(s):
Noriharu Shijubo, Isao Kawabata, Noriyuki Sato and Yoshihisa Itoh
Development and Application of Bioprobes for Mammalian Cell Cycle Analyses
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
727-732
Author(s):
Hiroyuki Osada
Ligand-Protein Docking: Cancer Research at the Interface between Biology and Chemistry
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
763-777
Author(s):
R. C. Glen and S. C. Allen
Eplerenone, a New Selective Aldosterone Blocker
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1065-1075
Author(s):
Ellen G. McMahon
Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1103-1114
Author(s):
Arthur G. Taveras, Paul Kirschmeier and Charles M. Baum
Drugs Acting on the Beta Isoform of Human Topoisomerase II (p180)
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
173-185
Author(s):
B. Gatto and E. Leo